Phil Nadeau
Stock Analyst at TD Cowen
(4.54)
# 973
Out of 4,408 analysts
790
Total ratings
48.5%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Phil Nadeau
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics | Maintained: Buy | n/a | $42.36 | - | 17 | Jun 11, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | n/a | $2.30 | - | 4 | Jun 8, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $3.01 | - | 15 | Jun 3, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $55.65 | +115.63% | 83 | May 21, 2026 | |
| BIIB Biogen | Maintained: Buy | $215 | $198.64 | +8.24% | 52 | May 14, 2026 | |
| KURA Kura Oncology | Maintained: Buy | n/a | $9.54 | - | 21 | May 12, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | n/a | $19.19 | - | 19 | May 11, 2026 | |
| AURA Aura Biosciences | Maintained: Buy | n/a | $6.45 | - | 13 | May 11, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | n/a | $3.63 | - | 40 | May 7, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | n/a | $8.61 | - | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.64 | - | 18 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.21 | - | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $159.51 | +25.38% | 56 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $450.46 | +16.55% | 85 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.46 | - | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $89.70 | +44.93% | 35 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.48 | - | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $18.19 | - | 6 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $41.95 | - | 29 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.98 | n/a | 18 | Mar 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0004 | n/a | 27 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.66 | n/a | 31 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.63 | n/a | 4 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.66 | n/a | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $75 | $124.30 | n/a | 44 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.86 | n/a | 12 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.94 | n/a | 7 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.86 | n/a | 6 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $385 | $614.98 | n/a | 40 | Feb 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.59 | n/a | 14 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $16 | $0.0001 | n/a | 14 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $205 | $350.53 | n/a | 1 | Jul 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.96 | n/a | 1 | May 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 | $549.57 | n/a | 5 | Apr 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.77 | n/a | 1 | Aug 7, 2015 |
Enliven Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $42.36
Upside: -
Century Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $2.30
Upside: -
Cabaletta Bio
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $3.01
Upside: -
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $120
Current: $55.65
Upside: +115.63%
Biogen
May 14, 2026
Maintained: Buy
Price Target: $215
Current: $198.64
Upside: +8.24%
Kura Oncology
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $9.54
Upside: -
MoonLake Immunotherapeutics
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $19.19
Upside: -
Aura Biosciences
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.45
Upside: -
Voyager Therapeutics
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $3.63
Upside: -
Vir Biotechnology
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $8.61
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $4.64
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $23.21
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $200
Current: $159.51
Upside: +25.38%
May 5, 2026
Maintained: Buy
Price Target: $525
Current: $450.46
Upside: +16.55%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $2.46
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $130
Current: $89.70
Upside: +44.93%
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $18.48
Upside: -
Apr 29, 2026
Maintained: Buy
Price Target: n/a
Current: $18.19
Upside: -
Mar 18, 2026
Maintained: Hold
Price Target: n/a
Current: $41.95
Upside: -
Mar 9, 2025
Maintained: Buy
Price Target: n/a
Current: $9.98
Upside: n/a
Nov 13, 2024
Rated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Oct 31, 2024
Maintained: Buy
Price Target: n/a
Current: $28.66
Upside: n/a
Mar 22, 2024
Rated: Hold
Price Target: n/a
Current: $6.63
Upside: n/a
Feb 13, 2023
Downgraded: Hold
Price Target: n/a
Current: $11.66
Upside: n/a
Feb 4, 2021
Maintained: Buy
Price Target: $80 → $75
Current: $124.30
Upside: n/a
Nov 9, 2020
Reiterated: Buy
Price Target: n/a
Current: $12.86
Upside: n/a
Aug 7, 2019
Maintained: Buy
Price Target: n/a
Current: $1.94
Upside: n/a
Feb 26, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $2.86
Upside: n/a
Feb 6, 2019
Rated: Hold
Price Target: $385
Current: $614.98
Upside: n/a
Jan 17, 2019
Maintained: Hold
Price Target: n/a
Current: $3.59
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $2 → $16
Current: $0.0001
Upside: n/a
Jul 26, 2018
Rated: Buy
Price Target: $205
Current: $350.53
Upside: n/a
May 3, 2016
Reiterated: Hold
Price Target: n/a
Current: $1.96
Upside: n/a
Apr 28, 2016
Reiterated: Buy
Price Target: $185
Current: $549.57
Upside: n/a
Aug 7, 2015
Reiterated: Hold
Price Target: n/a
Current: $15.77
Upside: n/a